STAT — Reporting from the frontiers of health and medicine
- Politics 7 policies in Biden’s spending plan aimed at health equity
- Pharmalot Socially responsible investor coalitions push greater access to medicines in shareholder proposals
- First Opinion Stigma, not science, is the biggest barrier to ending the HIV epidemic
- First Opinion Losing Faith: Reflecting on 40 years of the HIV pandemic
- Biotech FDA panel narrowly recommends authorization of first antiviral pill to treat Covid-19
- Politics 7 policies in Biden’s spending plan aimed at health equity
- Pharmalot Socially responsible investor coalitions push greater access to medicines in shareholder proposals
- First Opinion Stigma, not science, is the biggest barrier to ending the HIV epidemic
- First Opinion Losing Faith: Reflecting on 40 years of the HIV pandemic
- Biotech FDA panel narrowly recommends authorization of first antiviral pill to treat Covid-19
Exclusive analysis of biotech, pharma, and the life sciences
-
McDonald’s accused of dragging its feet on goal of reducing antibiotic use in beef supplies
-
Pfizer sues former employee for allegedly stealing Covid-19 vaccine documents
-
Pharmalittle: Moderna CEO cautions Covid shots will be less effective against Omicron; Pfizer predicts new vaccine for the variant in 100 days
- Health A reason for optimism on Omicron: Our immune systems are not blank slates
- Biotech FDA panel narrowly recommends authorization of first antiviral pill to treat Covid-19
- Health Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson
-
- Health What’s known and unknown about Omicron, the coronavirus variant identified in South Africa
- Biotech Pfizer research head envisions a sprint to develop Omicron vaccine, if it’s needed
- Health Doctors hope Omicron causes milder cases of Covid — but it’s still too early to say
- Politics 7 policies in Biden’s spending plan aimed at health equity
- Health The Covid-19 Tracker
